These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. T-cell-mediated suppression of Epstein-Barr virus-induced B lymphocyte activation in multiple sclerosis. Craig JC; Haire M; Merrett JD Clin Immunol Immunopathol; 1988 Sep; 48(3):253-60. PubMed ID: 2841052 [TBL] [Abstract][Full Text] [Related]
3. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice. Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263 [TBL] [Abstract][Full Text] [Related]
4. Abnormal responses of rheumatoid arthritis lymphocytes to Epstein-Barr virus infection in vitro: evidence for multiple defects. Irving WL; Walker PR; Lydyard PM Ann Rheum Dis; 1985 Jul; 44(7):462-8. PubMed ID: 2992398 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of interleukin-4 induction and interferon-gamma inhibition of IgE secretion by Epstein-Barr virus-infected human peripheral blood B cells. Thyphronitis G; Banchereau J; Heusser C; Tsokos GC; Levine AD; Finkelman FD Cell Immunol; 1991 Apr; 133(2):408-19. PubMed ID: 1849800 [TBL] [Abstract][Full Text] [Related]
6. B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines. Matsushima K; Kuang YD; Tosato G; Hopkins SJ; Oppenheim JJ Cell Immunol; 1985 Sep; 94(2):406-17. PubMed ID: 2992808 [TBL] [Abstract][Full Text] [Related]
7. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis. Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077 [TBL] [Abstract][Full Text] [Related]
8. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. Tosato G; Magrath IT; Blaese RM J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959 [TBL] [Abstract][Full Text] [Related]
9. Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals. Metes D; Storkus W; Zeevi A; Patterson K; Logar A; Rowe D; Nalesnik MA; Fung JJ; Rao AS Transplantation; 2000 Nov; 70(10):1507-15. PubMed ID: 11118098 [TBL] [Abstract][Full Text] [Related]
10. Concanavalin A induces a T-cell dependent activation of human tonsil B cells in vitro. Vitiello A; Nespoli L; Lanzavecchia A; Maccario R; Ugazio AG Thymus; 1980 Jan; 1(4-5):215-23. PubMed ID: 6969473 [TBL] [Abstract][Full Text] [Related]
11. B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes. Tosato G; Magrath IT; Koski IR; Dooley NJ; Blaese RM J Clin Invest; 1980 Aug; 66(2):383-8. PubMed ID: 6249850 [TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus-induced production of IgE by human B cells. Martinez-Maza O; Guilbert B; David B; Avrameas S Clin Immunol Immunopathol; 1986 Jun; 39(3):405-13. PubMed ID: 3009065 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture. Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells. Konttinen YT; Bluestein HG; Zvaifler NJ J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749 [TBL] [Abstract][Full Text] [Related]
15. Rescue of IgM, IgG, and IgA production in common varied immunodeficiency by T cell-independent stimulation with Epstein-Barr virus. Jeong G; Ralph P; Nakoinz I; Saiki O; Cunningham-Rundles C J Clin Immunol; 1985 Mar; 5(2):122-9. PubMed ID: 2985642 [TBL] [Abstract][Full Text] [Related]
16. Frequencies of the separate human B cell subsets activatable to Ig secretion by Epstein-Barr virus and pokeweed mitogen. Martínez-Maza O; Britton S J Exp Med; 1983 Jun; 157(6):1808-14. PubMed ID: 6304226 [TBL] [Abstract][Full Text] [Related]
17. [The regulation of B-lymphocyte activity by the Epstein-Barr virus in ankylosing spondylarthritis]. Peĭcheva V; Kan A; Amor B Vutr Boles; 1990; 29(5):88-91. PubMed ID: 1964317 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the specific IgM and IgG antibody response in humans induced by antigen (tetanus toxoid) or a polyclonal activator (EBV) in vitro. Kozbor D; Roder JC Int Arch Allergy Appl Immunol; 1983; 72(3):260-6. PubMed ID: 6311755 [TBL] [Abstract][Full Text] [Related]
19. alpha-Interferon increases immunoglobulin production in cultured human mononuclear leukocytes. Rodriguez MA; Prinz WA; Sibbitt WL; Bankhurst AD; Williams RC J Immunol; 1983 Mar; 130(3):1215-9. PubMed ID: 6296232 [TBL] [Abstract][Full Text] [Related]
20. Induction and abrogation of suppressor cell function in humans: effect on B cell activation by different polyclonal activators. Lilic D; Petersen J; Hesse J; Andersen V Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):251-5. PubMed ID: 6295061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]